Expired Tender USA ICB TOT Ref. 125591325

Department of Defense Pharmacy Uniform Formulary Tender - 125591325

Tender notice from USA, published on 03 Sep 2025.

Executive Summary

The DEPT OF DEFENSE | DEFENSE HEALTH AGENCY (DHA) has issued a Tender notice for the procurement of a Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formular Additional Discount Program in the USA. This Tender notice was published on 03 Sep 2025 and is scheduled to close on 18 Sep 2025, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 125591325, while the tender notice number is HT9402-25-Q-9403 and Register on the platform.

Key facts

Summary
Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formular Additional Discount Program
TOT Ref. No.
125591325
Document Ref. No.
HT9402-25-Q-9403
Country
USA
Notice type
Tender
Competition
ICB
Publication date
03 Sep 2025
Bid deadline
18 Sep 2025
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Description
The Department of Defense (DoD) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoD Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoD Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ.
P&T COMMITTEE MEETING: The following November 2025 drug classes/subclass or newly approved drugs will be reviewed:
a. Anzupgo - Atopy - Subclass: N/Ab. Brinsupri - Pulmonary-1 Agents - Subclass: N/Ac. Brynovin - Diabetes Non-Insulin - Subclass: DPP-4 Inhibitorsd. Ekterly - Corticosteroids-Immune Modulators - Subclass: Hereditary Angioedema Agentse. Harliku - Metabolic Agents-Miscellaneous - Subclass: Replacement Enzymesf. Hernexeos - Oncological Agents - Subclass: N/Ag. Kirsty - Insulins - Subclass: Rapid-Acting Agents U-100h. Lopressor - Beta Blockers and Hydrochlorothiazide Combinations - Subclass: N/Ai. Modeyso - Oncological Agents - Subclass: N/Aj. Orlynvah - Antibiotics - Subclass: Beta-lactamsk. Sephience - Metabolic Agents-Miscellaneous - Subclass: N/Abr...
Active Contract Opportunity

Notice ID : HT9402-25-Q-9403

Related Notice

Department/Ind. Agency : DEPT OF DEFENSE

Sub-tier : DEFENSE HEALTH AGENCY (DHA)

Office: DEFENSE HEALTH AGENCY

General Information

Contract Opportunity Type: Solicitation (Original)

Original Published Date: Sep 02, 2025 05:03 pm EDT

Original Date Offers Due: Sep 18, 2025 12:00 pm EDT

Inactive Policy: Manual

Original Inactive Date: Feb 28, 2026

Initiative: None
Classification

Original Set Aside:

Product Service Code: 6505 - DRUGS AND BIOLOGICALS

NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Place of Performance: San Antonio, TX 78230 USA

Documents

Tender Notice
Login to view
RFQ-HT9402-25-Q-9403-NAD.pdf
Login to view
Price-List-Anzupgo-Atopy-NA.xlsx
Login to view
Price-List-Brinsupri-Pulmonary-1-Agents-NA.xlsx
Login to view
Price-List-Brynovin-Diabetes-Non-Insulin-DPP.xlsx
Login to view
Price-List-Ekterly-Corticosteroids-Immune-Modu.xlsx
Login to view
Price-List-Harliku-Metabolic-Agents-Miscellane.xlsx
Login to view
Price-List-Hernexeos-Oncological-Agents-NA.xlsx
Login to view
Price-List-Kirsty-Insulins-Rapid-Acting-Agen.xlsx
Login to view
Price-List-Lopressor-Beta-Blockers-and-Hydroch.xlsx
Login to view
Price-List-Modeyso-Oncological-Agents-NA.xlsx
Login to view
Price-List-Orlynvah-Antibiotics-Beta-lactams.xlsx
Login to view
Price-List-Sephience-Metabolic-Agents-Miscella.xlsx
Login to view
DoD-Formulary-Placement-of-FDA-Newly-Approved-Drug.pdf
Login to view
Price-Appendix-FAQ-NAD.pdf
Login to view

USA Public Procurement Intelligence

Frequently asked questions

The bid deadline for Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formular Additional Discount Program was 18 Sep 2025. Bidding is closed.

This tender has been issued by DEPT OF DEFENSE | DEFENSE HEALTH AGENCY (DHA) in USA.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 125591325. The purchaser document reference is HT9402-25-Q-9403.

Browse other tenders from USA or search by relevant keywords and CPV classification.